Morningside Ventures Leads $15M Round In Luqa Pharma

This Data Is Locked!

This area is available only to Subscribers.

Hong Kong-headquartered Luqa Pharmaceuticals, a dermatology specialty company, has completed US$15 million new round of financing led by Morningside Ventures, according to a company announcement.... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?